Cape Investment Advisory, Inc. Royalty Pharma PLC Transaction History
Cape Investment Advisory, Inc.
- $256 Billion
- Q4 2024
A detailed history of Cape Investment Advisory, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 36 shares of RPRX stock, worth $1,161. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36Holding current value
$1,161% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
422Shares Held
282MCall Options Held
577KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.32 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$742 Million0.01% of portfolio
-
Baillie Gifford & CO14.1MShares$456 Million0.28% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$392 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...